Advertisement

Topics

Latest "Human medicines European public assessment report EPAR Ebymect" News Stories

11:27 EST 19th December 2018 | BioPortfolio

Here are the most relevant search results for "Human medicines European public assessment report EPAR Ebymect" found in our extensive news archives from over 250 global news sources.

More Information about Human medicines European public assessment report EPAR Ebymect on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Human medicines European public assessment report EPAR Ebymect for you to read. Along with our medical data and news we also list Human medicines European public assessment report EPAR Ebymect Clinical Trials, which are updated daily. BioPortfolio also has a large database of Human medicines European public assessment report EPAR Ebymect Companies for you to search.

Showing "Human medicines European public assessment report EPAR Ebymect" News Articles 1–25 of 45,000+

Wednesday 19th December 2018

France Regional Anesthesia Disposables Market Outlook to 2025 [Report Updated: 03102018] Prices from USD $4246

France Regional Anesthesia Disposables Market Outlook to 2025SummaryGlobalData's new report, France Regional Anesthesia Disposables Market Outlook to 2025, provides key market data on the France Regional Anesthesia Disposables market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Combined Spinal Epidural Disposables, Epidural A...


Ulcerative Colitis: Global Drug Forecast and Market Analysis to 2026 [Report Updated: 26062018] Prices from USD $9346

Ulcerative Colitis: Global Drug Forecast and Market Analysis to 2026SummaryInflammatory bowel disease IBD refers to two chronic autoimmune diseases that cause intestinal inflammation: Crohn's disease CD and ulcerative colitis UC. In UC, chronic inflammation affects the colon or large intestines, which are synonymous terms. UC usually manifests initially in the terminal part of the colon, the rectu...

Sarah Cannon Research Institute LLC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummarySarah Cannon Research Institute LLC SCRI is a research institute that offers integrated cancer services. The institute conducts clinical research programs for advancing cancer therapies. Its services include blood cancer network, cancer care overview, cardiovascular research, contract research organization, nurse navigators, oncology research, personalized medicine, radiation oncology, and ...


Stallergenes Greer plc STAGR Financial and Strategic SWOT Analysis Review [Report Updated: 13122018] Prices from USD $125

Stallergenes Greer plc STAGR Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augme...

Best’s Market Segment Report: Rising Medical Costs, Payrolls and Legal Expenses Threaten U.S. Workers’ Compensation Profitability

The U.S. workers’ compensation segment continued its positive performance in 2017, which was boosted by another year of growing payrolls that helped offset rate decreases and overall soft-market conditions, according to a new AM Best report. The Best’s Market Segment Report, “Workers’ Compensation Profitability Threatened by Rising Medical...

Antibacterial silver coating technology: Application for approval of human clinical study submitted to Federal Institute for Drugs and Medical Devices (BfArM)

DGAP-News: aap Implantate AG / Key word(s): Regulatory Admission 19.12.2018 / 15:30 The issuer is solely responsible for the content of this announcement. aap Implantate AG ("aap") announces that the application for approval to conduct a human clinical study for its antibacterial silver coating technology was today submitted to the Federal Institute for Drugs and Medical Devices (BfArM)...

Dr. Yun Li Joins VIC Technology Venture Development™ as Managing Director – New Mexico Branch

Executive with Extensive Startup Business Experience Leads VIC’s New Mexico Expansion FAYETTEVILLE, Ar. (PRWEB) December 19, 2018 VIC Technology Venture Development™ (VIC) is pleased to welcome Dr. Yun Li as Managing Director – New Mexico Branch. Dr. Li is also serving as interim CEO of VIC portfolio company Nob Hill Therapeutics, Inc. Her multifaceted professional career spans from R&...

Canada Neurological Diagnostic and Monitoring Equipment Market Outlook to 2025 [Report Updated: 19102018] Prices from USD $4246

Canada Neurological Diagnostic and Monitoring Equipment Market Outlook to 2025SummaryGlobalData's new report, Canada Neurological Diagnostic and Monitoring Equipment Market Outlook to 2025, provides key market data on the Canada Neurological Diagnostic and Monitoring Equipment market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segment...

Celebrating a lifetime in cancer biology, an early diagnosis champion, and our leaders of tomorrow: the 2018 CRUK Research Prizes

Research Feature   Our annual Research Prizes recognise the achievements of the rising stars in cancer research and celebrate the researchers who have shown outstanding dedication to beating cancer. In November, we returned to the NCRI Conference in Glasgow to award our prizes for the ninth year. Our leaders of tomorrow: the Future Leaders Prize The Future Leaders in Cancer Research Prize re...

Medica Awards $70,000 in Grants to Nebraska Health Care Organizations

Magis Clinic and Visiting Nurse Association Receive Funding Medica today announced grants totaling $70,000 to two Omaha, Neb., health care organizations. The Magis Clinic at Creighton University’s School of Medicine in Omaha will receive $20,000 to expand its prescription drug program and its immunization program for people experiencing homelessness....

ProtoKinetix Releases First in a Series of Scientific Update Videos

ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB:PKTX) announces the launch of the first in a series of informational videos by the Principal Investigators in each field currently being tested. The first video is an update on the clinical trial of AAGP™ PKX-001 treated

Health Insurance Executive Pay Rises, According to BDO Report

Annual Incentive Plans Putting Greater Focus on Revenue Growth and Benefit Cost Containment Health insurance CEO salaries have increased at an annual rate of 4 percent over the last 10 years, higher than the average budgeted employee salary merit increase of 3 percent, according to a new report from BDO USA, LLP. Total direct compensation for CEOs and ...

Turnover Within CRO Companies Remains Persistently High, According to BDO Report

CRO Industry Compensation Strategies See Little Change Over the Last Decade Clinical Research Outsourcing (CRO) companies are battling high turnover levels, but a new report from BDO USA, LLP, finds that compensation strategies generally have not made significant enough adjustments to their compensation strategy to address this issue. T...

Mice no more? Hesperos’ Multi-organ “Human-on-a-Chip” System Found Effective for Long-Term Toxicology Testing

Collaboration between L’Oreal, Hesperos and UCF results in further reduction in reliance on animal testing in drug and cosmetics development The replacement of animals as test subjects is one step closer to reality with the successful testing of multi-organ “human-on-a-chip” models to recapitulate the 28 day experiments typically used in animals ...

NHS safety culture needs radical change, says CQC

The safety culture of the NHS must transform radically to reduce “never events” that continue to happen despite the efforts of frontline staff, a report from the Care Quality Commission (CQC) has...

Tough Path Through Middle School Ensues For Tween Boys. Sweetness Fades And ‘Manhood’ Emerges.

It's a time when many boys shut themselves off from the world, says psychologist Michael Thompson, leading to social problems. “Are you strong enough? Are you athletic enough? And in middle school: Are your muscles big enough?” he explains. “That’s middle school for boys, and that’s pretty crappy.” Public health news also focuses on diagnosing child abuse, the benefits of exercise, men...

Despite Rampant Warning Signs Of Abuse, Drug Companies And DEA Failed To Stem Flood Of Opioids Into West Virginia

The House Energy and Commerce Committee report, which was the culmination of an 18-month investigation of alleged pill dumping in West Virginia, shows how mistakes and lack of oversight led to a massive influx of pills there. In other news on the epidemic: overdose antidotes, hep C testing, marketing of opioids, syringes, and more.

Millions Of Dollars Budgeted For Suicide Outreach To Veterans Goes Unspent Even As Rates Continue To Rise

A GAO report released this week says that bureaucratic confusion and vacancies in key posts are largely to blame for the Department of Veterans Affairs' failure to support suicide prevention efforts.

Nippon Kayaku Co Ltd 4272 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryNippon Kayaku Co Ltd Nippon Kayaku is a chemical company, which undertakes the development, manufacturing and sale of functional chemicals, pharmaceuticals and safety systems. The company's product portfolio includes epoxy resins, UVcuring type resins, optical functional films, colors for inkjet printers, catalysts, pharmaceuticals, active pharmaceutical ingredients APIs and intermediates, ...

Spectranetics Corp Medical Equipment Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummarySpectranetics Corp Spectranetics is a medical device company that manufactures and distributes disposable medical devices. The company provides peripheral intervention, lead management and coronary intervention products. It offers peripheral and cardiac laser catheters for ablation of stenosed and occluded arteries. Spectranetics also offers coronary laser atherectomy catheters, scoring bal...

Pharmaceutical Contract Manufacturing Service: Procurement Research, Market Intelligence, Supply Market Forecasts, Cost Drivers, Trends, Category Management Insights Now Available from SpendEdge

SpendEdge, a global procurement market intelligence firm, has announced the release of their Global Pharmaceutical Contract Manufacturing Service Category - Procurement Market Intelligence Report. This press release features multimedia. View the full release here:

Cerus Announces First Patient Enrolled in the Phase 3 ReCePI Study

Cerus Corporation (Nasdaq:CERS) today announced the initiation and first patient enrollment in ReCePI, a randomized, double-blinded, controlled, parallel group, non-inferiority, Phase 3 study to evaluate the efficacy and safety of the INTERCEPT Blood System for red blood cells in patients undergoing complex cardiac surgery procedures. The first patient was ...

X-Chem Enters Strategic Collaboration with Bristol-Myers Squibb

X-Chem, Inc., a privately held biotechnology company focused on applying its industry-leading DNA-encoded (DEX™) library drug discovery engine to the generation of novel small molecule therapeutics, today announced the signing of a broad strategic drug discovery collaboration with Bristol-Myers Squibb. The collaboration will enable the discovery of ...

Salt reduction: food companies fail to achieve half of government targets, report finds

Only half of the targets for cutting salt content in the foods that contribute most to UK adults’ salt intake have been met, a progress assessment by Public Health England has reported.1The salt...

Gilead Sciences and Scholar Rock Announce Strategic Collaboration to Develop Novel Therapies for Fibrotic Diseases

– Companies to Develop Highly Specific Inhibitors of Local TGFβ Activation – Gilead Sciences, Inc. (NASDAQ: GILD) and Scholar Rock Holding Corporation (NASDAQ: SRRK) announced today that the companies have entered into a strategic collaboration to discover and develop highly specific inhibitors of transforming growth factor beta (TGFβ) activation...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks